# Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma

> **NCT00046852** · PHASE1,PHASE2 · COMPLETED · sponsor: **University of Maryland, Baltimore**

## Conditions studied

- Infection
- Multiple Myeloma and Plasma Cell Neoplasm

## Interventions

- **BIOLOGICAL:** filgrastim
- **BIOLOGICAL:** pneumococcal polyvalent vaccine
- **BIOLOGICAL:** therapeutic autologous lymphocytes
- **BIOLOGICAL:** therapeutic tumor infiltrating lymphocytes
- **DRUG:** carmustine
- **DRUG:** cyclophosphamide
- **DRUG:** melphalan
- **PROCEDURE:** bone marrow ablation with stem cell support
- **PROCEDURE:** peripheral blood stem cell transplantation

## Key facts

- **NCT ID:** NCT00046852
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-12
- **Primary completion:** 2004-11
- **Final completion:** 2008-02
- **Target enrollment:** — (—)
- **Last updated:** 2019-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00046852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00046852, "Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma". Retrieved via AI Analytics 2026-07-07 from https://api.ai-analytics.org/clinical/NCT00046852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*